chr22-40349925-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_000026.4(ADSL):​c.247C>T​(p.Arg83Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000145 in 1,614,090 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R83H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00015 ( 2 hom. )

Consequence

ADSL
NM_000026.4 missense

Scores

1
7
10

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 2.29

Publications

3 publications found
Variant links:
Genes affected
ADSL (HGNC:291): (adenylosuccinate lyase) The protein encoded by this gene belongs to the lyase 1 family. It is an essential enzyme involved in purine metabolism, and catalyzes two non-sequential reactions in the de novo purine biosynthetic pathway: the conversion of succinylaminoimidazole carboxamide ribotide (SAICAR) to aminoimidazole carboxamide ribotide (AICAR) and the conversion of adenylosuccinate (S-AMP) to adenosine monophosphate (AMP). Mutations in this gene are associated with adenylosuccinase deficiency (ADSLD), a disorder marked with psychomotor retardation, epilepsy or autistic features. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2015]
ADSL Gene-Disease associations (from GenCC):
  • adenylosuccinate lyase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.053032428).
BP6
Variant 22-40349925-C-T is Benign according to our data. Variant chr22-40349925-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 195007.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000026.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADSL
NM_000026.4
MANE Select
c.247C>Tp.Arg83Cys
missense
Exon 2 of 13NP_000017.1X5D8S6
ADSL
NM_001410812.1
c.247C>Tp.Arg83Cys
missense
Exon 2 of 14NP_001397741.1A0A7P0Z472
ADSL
NM_001363840.3
c.247C>Tp.Arg83Cys
missense
Exon 2 of 14NP_001350769.1A0A1B0GWJ0

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADSL
ENST00000623063.3
TSL:1 MANE Select
c.247C>Tp.Arg83Cys
missense
Exon 2 of 13ENSP00000485525.1P30566-1
ADSL
ENST00000342312.9
TSL:1
c.247C>Tp.Arg83Cys
missense
Exon 2 of 12ENSP00000341429.6P30566-2
ADSL
ENST00000480775.3
TSL:1
n.247C>T
non_coding_transcript_exon
Exon 2 of 13ENSP00000485462.2A0A096LP92

Frequencies

GnomAD3 genomes
AF:
0.000131
AC:
20
AN:
152102
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000962
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000131
AC:
33
AN:
251486
AF XY:
0.000110
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00103
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000879
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000146
AC:
213
AN:
1461870
Hom.:
2
Cov.:
32
AF XY:
0.000146
AC XY:
106
AN XY:
727238
show subpopulations
African (AFR)
AF:
0.0000597
AC:
2
AN:
33480
American (AMR)
AF:
0.0000224
AC:
1
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.000479
AC:
19
AN:
39700
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.000152
AC:
169
AN:
1111990
Other (OTH)
AF:
0.000348
AC:
21
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
12
24
37
49
61
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000138
AC:
21
AN:
152220
Hom.:
0
Cov.:
31
AF XY:
0.000148
AC XY:
11
AN XY:
74436
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41542
American (AMR)
AF:
0.000131
AC:
2
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.000964
AC:
5
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10594
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68012
Other (OTH)
AF:
0.000473
AC:
1
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.552
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000679
Hom.:
0
Bravo
AF:
0.0000907
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.000148
AC:
18
Asia WGS
AF:
0.00144
AC:
5
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000178

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
1
Adenylosuccinate lyase deficiency (2)
-
2
-
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.19
T
BayesDel_noAF
Benign
-0.11
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.19
T
Eigen
Benign
-0.24
Eigen_PC
Benign
-0.36
FATHMM_MKL
Benign
0.38
N
LIST_S2
Pathogenic
0.99
D
M_CAP
Uncertain
0.11
D
MetaRNN
Benign
0.053
T
MetaSVM
Uncertain
0.24
D
MutationAssessor
Uncertain
2.5
M
PhyloP100
2.3
PrimateAI
Benign
0.26
T
PROVEAN
Uncertain
-3.5
D
REVEL
Uncertain
0.39
Sift
Benign
0.032
D
Sift4G
Uncertain
0.036
D
Polyphen
0.65
P
Vest4
0.34
MutPred
0.43
Gain of catalytic residue at L84 (P = 0.0111)
MVP
0.90
MPC
0.88
ClinPred
0.14
T
GERP RS
2.3
Varity_R
0.20
gMVP
0.60
Mutation Taster
=81/19
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs780425464; hg19: chr22-40745929; COSMIC: COSV53408868; COSMIC: COSV53408868; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.